BNO 5.26% 20.0¢ bionomics limited

Analyst report says Buy, page-11

  1. 169 Posts.
    lightbulb Created with Sketch. 3
    Great to see all the analysts from HC Wainright, Bell Potter and Shaws backing such a great and undervalued story. I see only great things and upside for this company from here. It is also rightly so in Bell Potter analyst Tanushree Jain's Top picks for FY18.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.